Patents by Inventor Catherine Guillou

Catherine Guillou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of indole for the treatment of cancer, viral infections and lung diseases
    Patent number: 10851054
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: December 1, 2020
    Assignees: BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Cecile Bougeret, Catherine Guillou, Julien Rouleau, Julie Rivollier, Denis Carniato
  • NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES
    Publication number: 20190169124
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Application
    Filed: January 25, 2019
    Publication date: June 6, 2019
    Inventors: CECILE BOUGERET, CATHERINE GUILLOU, JULIEN ROULEAU, JULIE RIVOLLIER, DENIS CARNIATO
  • Derivatives of indole for the treatment of cancer, viral infections and lung diseases
    Patent number: 10189782
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: January 29, 2019
    Assignees: BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Cecile Bougeret, Catherine Guillou, Julien Rouleau, Julie Rivollier, Denis Carniato
  • NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES
    Publication number: 20170233342
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Application
    Filed: May 4, 2017
    Publication date: August 17, 2017
    Inventors: CECILE BOUGERET, CATHERINE GUILLOU, JULIEN ROULEAU, JULIE RIVOLLIER, DENIS CARNIATO
  • Derivatives of indole for the treatment of cancer, viral infections and lung diseases
    Patent number: 9643923
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: May 9, 2017
    Assignees: BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Cécile Bougeret, Catherine Guillou, Julien Rouleau, Julie Rivollier, Denis Carniato
  • Use of derivatives of indoles for the treatment of cancer
    Patent number: 9212138
    Abstract: The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: December 15, 2015
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Catherine Guillou, Frank Kozielski, Christophe Labriere, Francoise Gueritte, Sergey Tcherniuk, Dimitrios Skoufias, Claude Thal, Henri-Philippe Husson
  • NEW DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER, VIRAL INFECTIONS AND LUNG DISEASES
    Publication number: 20150307450
    Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
    Type: Application
    Filed: December 6, 2013
    Publication date: October 29, 2015
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, BIOKINESIS
    Inventors: Cécile Bougeret, Catherine Guillou, Julien Rouleau, Julie Rivollier, Denis Carniato
  • USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER
    Publication number: 20140235654
    Abstract: The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.
    Type: Application
    Filed: February 12, 2014
    Publication date: August 21, 2014
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Catherine GUILLOU, Frank KOZIELSKI, Christophe LABRIERE, Francoise GUERITTE, Sergey TCHERNIUK, Dimitrios SKOUFIAS, Claude THAL, Henri-Philippe HUSSON
  • Use of derivatives of indoles for the treatment of cancer
    Patent number: 8703808
    Abstract: The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: April 22, 2014
    Assignees: Centre National de la Recherche Scientifique, Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: Catherine Guillou, Frank Kozielski, Christophe Labriere, Francoise Gueritte, Sergey Tcherniuk, Dimitrios Skoufias, Claude Thal, Henri-Philippe Husson
  • USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER
    Publication number: 20130131084
    Abstract: The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.
    Type: Application
    Filed: August 17, 2012
    Publication date: May 23, 2013
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Catherine GUILLOU, Frank Kozielski, Christophe Labriere, Francoise Gueritte, Sergey Tcherniuk, Dimitrios Skoufias, Claude Thal, Henri-Philippe Husson
  • TETRACYCLIC TERPENE SERIES COMPOUNDS, METHODS FOR PREPARING SAME, USES THEREOF AS MEDICINES AND PHARMACEUTICAL COMPOUNDS CONTAINING SAME
    Publication number: 20120040930
    Abstract: The invention concerns a triterpene alkaloid of general formula (I). The invention also concerns a method for making same and use thereof as medicine.
    Type: Application
    Filed: January 13, 2006
    Publication date: February 16, 2012
    Inventors: Catherine Guillou, Jean-Yves Lallemand, Thibault Sauvaítre, Jordi Molgo, Denyse Herlem, Daniel Guenard, Françoise Khuong-Huu
  • Total synthesis of galanthamine, analogues and derivatives thereof
    Patent number: 7109327
    Abstract: The invention relates to a method for the synthesis of galanthamifle, the derivatives and analogues thereof of formula (1) where R1=a hydrogen atom.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: September 19, 2006
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Claude Thal, Catherine Guillou, Jean-Luc Beunard, Emmanuel Gras, Pierre Potier
  • Total synthesis of galanthamine, analogues and derivatives thereof
    Publication number: 20050065338
    Abstract: The invention relates to a method for the synthesis of galanthamine, the derivatives and analogues thereof of formula (1) where R1=a hydrogen atom. R2=a hydroxy group, R1 and R2 together form =0, R3, R4, and R5 independently=a hydrogen atom, a hydroxy group or a (C1-C2) alkoxy group, R6-11 , (C1-C12) alkyl, (CH2)nNR7R8, or —(CH2)nN?R7R8R9 where n?1 to 12 Z=two hydrogen atoms, or an oxygen atom and X=an oxygen, sulphur or nitrogen atom, or a —SO, —SO2, or —NR6 group where R6 is as defined above or is an amine protecting group.
    Type: Application
    Filed: June 14, 2002
    Publication date: March 24, 2005
    Inventors: Claude Thal, Catherine Guillou, Jean-Luc Beunard, Emmanuel Gras, Pierre Potier
  • Galanthamine derivatives, and their pharmaceutical compositions
    Patent number: 5958903
    Abstract: Novel galanthamine derivatives of general fonnulae (Ia) and (Ib), a method for preparing same, pharmaceutical compositions containing said derivatives, and their use, in particular as cholinesterase inhibitors, are disclosed.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: September 28, 1999
    Assignee: Societe de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Dolor Renko, Pierre Potier, Yves Christen, Claude Thal, Catherine Guillou, Aude Mary
  • Total synthesis of galanthamine, analogues and derivatives thereof
    Patent number: RE41366
    Abstract: The invention relates to a method for the synthesis of galanthamine, the derivatives and analogues thereof of formula (1) where R1=a hydrogen atom, R2=a hydroxy group, R1 and R2 together form ?O, R3, R4, and R5 independently=a hydrogen atom, a hydroxy group or a (C1-C2)alkoxy group, R6?H, (C1-C12)alkyl, (CH2)nNR7R8, or —(CH2)nN+R7R8R9 where n=1 to 12, Z=two hydrogen atoms, or an oxygen atom and X=an oxygen, sulphur or nitrogen atom, or a —SO, —SO2, or —NR6 group where R6 is as defined above or is an amine protecting group.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: June 1, 2010
    Assignee: Centre National del la Recherche Scientifique (CNRS)
    Inventors: Claude Thal, Catherine Guillou, Jean-Luc Beunard, Emmanuel Gras, Pierre Potier